SCHEMBL549145

SCHEMBL549145

Nc1c(-c2cc(Cl)ccc2O)nnn1-c1ccc(Cl)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
RAB9A P51151 1/20 0.40
HSD17B10 Q99714 2/20 0.40
TSHR P16473 1/20 0.40
NOTUM Q6P988 1/20 0.39
IDO1 P14902 3/20 0.38
PABPC1 P11940 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PIM1 P11309 1/20 0.37
LMNA P02545 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL549067 0.88 GABRA2 (0.46) ALDH1A1KMT2AMEN1NPC1TP53
SCHEMBL548988 0.80 TP53 (0.44) ALDH1A1L3MBTL1TP53
SCHEMBL549165 0.72 MEN1 (0.49) L3MBTL1KMT2AMEN1NPC1TP53
SCHEMBL548231 0.72 POLB (0.69) ALDH1A1L3MBTL1KMT2AMEN1NPC1
SCHEMBL28463382 0.71 L3MBTL1 (0.60) ALDH1A1L3MBTL1KMT2AMEN1NPC1
SCHEMBL23405487 0.67 TP53 (0.63) ALDH1A1KMT2AMEN1NPC1TP53
SCHEMBL23405504 0.67 TP53 (0.63) ALDH1A1KMT2AMEN1NPC1TP53
SCHEMBL548342 0.66 POLB (0.60) ALDH1A1L3MBTL1KMT2AMEN1NPC1
SCHEMBL549152 0.65 GABRA2 (0.58) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL6242615 0.65 HSD17B10 (0.62) ALDH1A1KMT2AMEN1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222398-A1 NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2010-09-02 US claimed
US-8110588-B2 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors NEUROSEARCH A/S (DK) 2012-02-07 US disclosed
US-20100222398-A1 NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222398-A1 NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA3, CHRNB3, CHRNA5 ALDH1A1 1573/4885L3MBTL1 4050/4885KMT2A 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.